SEC Form 4 · accession 0001645470-19-000007
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 28, 2019
Accepted (ET)
Jan 31, 2019 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 28, 2019 | P | 1,000 | $0.0278 | A | 20,994,623 | D | |
| Common Stock | Jan 28, 2019 | P | 1,000 | $0.028 | A | 20,995,623 | D | |
| Common Stock | Jan 28, 2019 | P | 1,000 | $0.0279 | A | 20,996,623 | D | |
| Common Stock | Jan 28, 2019 | P | 5,000 | $0.0313 | A | 21,001,623 | D | |
| Common Stock | Jan 28, 2019 | P | 10,000 | $0.0313 | A | 21,011,623 | D | |
| Common Stock | Jan 28, 2019 | P | 10,000 | $0.031 | A | 21,021,623 | D | |
| Common Stock | Jan 28, 2019 | P | 2,000 | $0.029 | A | 21,023,623 | D | |
| Common Stock | Jan 28, 2019 | P | 2,000 | $0.0279 | A | 21,025,623 | D | |
| Common Stock | Jan 29, 2019 | P | 5,000 | $0.0269 | A | 21,030,623 | D | |
| Common Stock | Jan 29, 2019 | P | 5,000 | $0.0265 | A | 21,035,623 | D | |
| Common Stock | Jan 29, 2019 | P | 5,000 | $0.0269 | A | 21,040,623 | D | |
| Common Stock | Jan 29, 2019 | P | 5,000 | $0.0261 | A | 21,045,623 | D | |
| Common Stock | Jan 29, 2019 | P | 5,000 | $0.0269 | A | 21,050,623 | D | |
| Common Stock | Jan 29, 2019 | P | 1,000 | $0.0265 | A | 21,051,623 | D | |
| Common Stock | Jan 29, 2019 | P | 1,000 | $0.0264 | A | 21,052,623 | D |
Table II — derivative securities
No Table II lines on this filing.